Prestige Consumer Healthcare Inc.

PBHNYSE • USD
46.19 USD
↗ 0.87 (1.92%)AT CLOSE (03:59 PM EST)
46.77
↗ 0.58 (1.25%)
POST MARKET (AS OF 07:45 PM EST)
Post Market
AS OF 07:45 PM EST
46.77
↗ 0.58 (1.25%)
🔴Market: CLOSED

Prestige Consumer Healthcare Inc. (PBH) trades at $46.19 per share. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Key drivers include a concerning Altman Z-Score in the distress zone, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, PBH appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Nov 13, 2026.

Open?$45.69
High?$46.41
Low?$45.23
Prev. Close?$45.32
Volume?500.4K
Avg. Volume?601.1K
VWAP?$46.01
Rel. Volume?0.83x
Bid / Ask
Bid?$45.93 × 200
Ask?$47.60 × 1.0K
Spread?$1.67
Midpoint?$46.77
Valuation & Ratios
Market Cap?2.1B
Shares Out?47.4M
Float?46.6M
Float %?98.5%
P/E Ratio?13.85
P/B Ratio?1.10
EPS?$3.27
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
Employees
890
Market Cap
2.1B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2005-02-10
Address
660 WHITE PLAINS RD.
TARRYTOWN, NY 10591
Phone: (914) 524-6800
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
21
Momentum?
50
Short Sent.?
60
Piotroski F-Score?3/9Weak
Altman Z-Score?1.53Distress
Confidence?71%Moderate
Full Fundamental Analysis →
Short Interest
Loading...
Financial Health
Current Ratio?2.92Strong
Quick Ratio?1.86Adequate
Cash Ratio?0.28Low
Debt/Equity?1.08Moderate
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
89/100
P/E?
Peers
100
S&P
85
13.9CHEAP▾
P/B?
Peers
100
S&P
95
1.10CHEAP▾
P/S?
Peers
100
S&P
70
1.84CHEAP▾
P/FCF?
Peers
100
S&P
88
10.0CHEAP▾
EV/EBITDA?
Peers
100
S&P
67
12.2FAIR▾
EV/Sales?
Peers
100
S&P
52
3.60FAIR▾
Returns & Efficiency
ROE?
Peers
50
S&P
25
8.0%FAIR▾
ROA?
Peers
50
S&P
30
3.3%FAIR▾
Cash Flow & Enterprise
FCF?$214.2M
Enterprise Value?$4.2B
Fundamentals ratios updated end of day